These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33356117)

  • 1. Structural and Molecular Dynamics of
    Burley KH; Cuthbert BJ; Basu P; Newcombe J; Irimpan EM; Quechol R; Foik IP; Mobley DL; Beste DJV; Goulding CW
    ACS Infect Dis; 2021 Jan; 7(1):174-188. PubMed ID: 33356117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anaplerotic node is essential for the intracellular survival of
    Basu P; Sandhu N; Bhatt A; Singh A; Balhana R; Gobe I; Crowhurst NA; Mendum TA; Gao L; Ward JL; Beale MH; McFadden J; Beste DJV
    J Biol Chem; 2018 Apr; 293(15):5695-5704. PubMed ID: 29475946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
    Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
    Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets.
    Shaku M; Ealand C; Kana BD
    Front Cell Infect Microbiol; 2020; 10():603382. PubMed ID: 33282752
    [No Abstract]   [Full Text] [Related]  

  • 8. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
    Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
    J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteria.
    Rodionova IA; Schuster BM; Guinn KM; Sorci L; Scott DA; Li X; Kheterpal I; Shoen C; Cynamon M; Locher C; Rubin EJ; Osterman AL
    mBio; 2014 Feb; 5(1):. PubMed ID: 24549842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weak spots inhibition in the
    Adewumi AT; Elrashedy A; Soremekun OS; Ajadi MB; Soliman MES
    J Biomol Struct Dyn; 2022 Apr; 40(7):2934-2954. PubMed ID: 33155529
    [No Abstract]   [Full Text] [Related]  

  • 11. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
    Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
    J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supramolecular organization and dynamics of mannosylated phosphatidylinositol lipids in the mycobacterial plasma membrane.
    Brown CM; Corey RA; Grélard A; Gao Y; Choi YK; Luna E; Gilleron M; Destainville N; Nigou J; Loquet A; Fullam E; Im W; Stansfeld PJ; Chavent M
    Proc Natl Acad Sci U S A; 2023 Jan; 120(5):e2212755120. PubMed ID: 36693100
    [No Abstract]   [Full Text] [Related]  

  • 13. Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B.
    Dhiman H; Dhanjal JK; Sharma S; Chacko S; Grover S; Grover A
    Biochem Biophys Res Commun; 2013 Apr; 433(4):552-7. PubMed ID: 23510997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking.
    Anuradha CM; Mulakayala C; Babajan B; Naveen M; Rajasekhar C; Kumar CS
    J Mol Model; 2010 Jan; 16(1):77-85. PubMed ID: 19484275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential Mycolyltransferase Ag85C inhibitors of Mycobacterium tuberculosis H37Rv via Virtual High Throughput Screening and Binding free energy studies.
    Pant R; Joshi A; Maiti P; Nand M; Pande V; Chandra S
    J Mol Graph Model; 2020 Jul; 98():107584. PubMed ID: 32200279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.
    Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R
    PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the structural coverage of tuberculosis drug targets.
    Baugh L; Phan I; Begley DW; Clifton MC; Armour B; Dranow DM; Taylor BM; Muruthi MM; Abendroth J; Fairman JW; Fox D; Dieterich SH; Staker BL; Gardberg AS; Choi R; Hewitt SN; Napuli AJ; Myers J; Barrett LK; Zhang Y; Ferrell M; Mundt E; Thompkins K; Tran N; Lyons-Abbott S; Abramov A; Sekar A; Serbzhinskiy D; Lorimer D; Buchko GW; Stacy R; Stewart LJ; Edwards TE; Van Voorhis WC; Myler PJ
    Tuberculosis (Edinb); 2015 Mar; 95(2):142-8. PubMed ID: 25613812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor binding studies of
    Mallavarapu BD; Abdullah M; Saxena S; Guruprasad L
    J Biomol Struct Dyn; 2019 Sep; 37(14):3751-3763. PubMed ID: 30239262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.